4.6 Article

Automated Reporter Quantification In Vivo: High-Throughput Screening Method for Reporter-Based Assays in Zebrafish

期刊

PLOS ONE
卷 7, 期 1, 页码 -

出版社

PUBLIC LIBRARY SCIENCE
DOI: 10.1371/journal.pone.0029916

关键词

-

资金

  1. National Institutes of Health [R44-HD047089, R41-DK082060, RC4-DK090816, R01-DK080730]
  2. March of Dimes Basil O'Conner Starter Scholar Award [5-FY10-7]
  3. Washington University Olin Cup Award
  4. Life Science Foundation of the Helmholtz Gemeinschaft and the Helmholtz Gemeinschaft
  5. Georgia Health Sciences University

向作者/读者索取更多资源

Reporter-based assays underlie many high-throughput screening (HTS) platforms, but most are limited to in vitro applications. Here, we report a simple whole-organism HTS method for quantifying changes in reporter intensity in individual zebrafish over time termed, Automated Reporter Quantification in vivo (ARQiv). ARQiv differs from current highcontent'' (e.g., confocal imaging-based) whole-organism screening technologies by providing a purely quantitative data acquisition approach that affords marked improvements in throughput. ARQiv uses a fluorescence microplate reader with specific detection functionalities necessary for robust quantification of reporter signals in vivo. This approach is: 1) Rapid; achieving true HTS capacities (i.e., >50,000 units per day), 2) Reproducible; attaining HTS-compatible assay quality (i.e., Z'-factors of >= 0.5), and 3) Flexible; amenable to nearly any reporter-based assay in zebrafish embryos, larvae, or juveniles. ARQiv is used here to quantify changes in: 1) Cell number; loss and regeneration of two different fluorescently tagged cell types (pancreatic beta cells and rod photoreceptors), 2) Cell signaling; relative activity of a transgenic Notch-signaling reporter, and 3) Cell metabolism; accumulation of reactive oxygen species. In summary, ARQiv is a versatile and readily accessible approach facilitating evaluation of genetic and/or chemical manipulations in living zebrafish that complements current high-content'' whole-organism screening methods by providing a first-tier in vivo HTS drug discovery platform.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biochemical Research Methods

NTR 2.0: a rationally engineered prodrug-converting enzyme with substantially enhanced efficacy for targeted cell ablation

Abigail Sharrock, Timothy S. Mulligan, Kelsi R. Hall, Elsie M. Williams, David T. White, Liyun Zhang, Kevin Emmerich, Frazer Matthews, Saumya Nimmagadda, Selena Washington, Katherine D. Le, Danielle Meir-Levi, Olivia L. Cox, Meera T. Saxena, Anne L. Calof, Martha E. Lopez-Burks, Arthur D. Lander, Ding Ding, Hongkai Ji, David F. Ackerley, Jeff S. Mumm

Summary: Researchers have developed an improved NTR 2.0 variant through rational engineering and cross-species screening, which significantly enhances cell-specific ablation efficacy without the need for toxic prodrug treatment. This discovery allows for enhanced investigations into cell function, stem cell niche regenerative capacity, and chronic degenerative diseases.

NATURE METHODS (2022)

Article Developmental Biology

A New Transgenic Line for Rapid and Complete Neutrophil Ablation

Christopher J. Hall, Jonathan W. Astin, Jeff S. Mumm, David F. Ackerley

Summary: This article investigates a new approach to target neutrophils using an improved variant of NTR, showing that it is more effective than current treatment regimens.

ZEBRAFISH (2022)

Article Cell & Tissue Engineering

Intrinsic epigenetic control of angiogenesis in induced pluripotent stem cell-derived endothelium regulates vascular regeneration

Bria L. Macklin, Ying-Yu Lin, Kevin Emmerich, Emily Wisniewski, Brian M. Polster, Konstantinos Konstantopoulos, Jeff S. Mumm, Sharon Gerecht

Summary: Human-induced pluripotent stem cell-derived endothelial cells (iECs) have angiogenic potential and their phenotype is regulated by epigenetics, indicating their potential therapeutic applications.

NPJ REGENERATIVE MEDICINE (2022)

Article Neurosciences

Notch Inhibition Promotes Regeneration and Immunosuppression Supports Cone Survival in a Zebrafish Model of Inherited Retinal Dystrophy

Joseph Fogerty, Ping Song, Patrick Boyd, Sarah E. Grabinski, Thanh Hoang, Adrian Reich, Lauren T. Cianciolo, Seth Blackshaw, Jeff S. Mumm, David R. Hyde, Brian D. Perkins

Summary: Zebrafish has the ability to regenerate retinal neurons and restore visual function, which is not permanent in mammals. However, in zebrafish models of retinal degeneration, photoreceptor death does not induce the regeneration of lost cells. Both MG reprogramming and proliferation of retinal progenitor cells require reactive microglia and associated inflammatory signaling.

JOURNAL OF NEUROSCIENCE (2022)

Article Biochemistry & Molecular Biology

Optimisation of pyrazolo[1,5-a]pyrimidin-7(4H)-one derivatives as novel Hsp90 C-terminal domain inhibitors against Ewing sarcoma

Ziva Zajec, Jaka Dernovsek, Martin Distel, Martina Gobec, Tihomir Tomasic

Summary: In this article, a new class of allosteric Hsp90 C-terminal domain (CTD) inhibitors based on the virtual screening hit TVS24 is reported, which showed anti-proliferative activity in the SK-N-MC Ewing sarcoma cell line. The optimized compounds exhibited enhanced anticancer activity in the SK-N-MC cell line. Exposure to the most potent analogue 11c depleted critical Hsp90 client proteins involved in cancer pathways without inducing a heat shock response. This study highlights Hsp90 CTD inhibitors as promising new agents for the treatment of Ewing sarcoma.

BIOORGANIC CHEMISTRY (2023)

Article Oncology

High-content drug screening in zebrafish xenografts reveals high efficacy of dual MCL-1/BCL-XL inhibition against Ewing sarcoma

Sarah Grissenberger, Caterina Sturtzel, Andrea Wenninger-Weinzierl, Branka Radic-Sarikas, Eva Scheuringer, Lisa Bierbaumer, Vesnie Etienne, Fariba Nemati, Susana Pascoal, Marcus Toetzl, Eleni M. Tomazou, Martin Metzelder, Eva M. Putz, Didier Decaudin, Olivier Delattre, Didier Surdez, Heinrich Kovar, Florian Halbritter, Martin Distel

Summary: High-throughput drug screening using zebrafish xenografts identified dual inhibition of anti-apoptotic proteins MCL-1 and BCL-XL as an effective strategy against Ewing sarcoma cells. The combination treatment showed enhanced efficacy compared to single agents in both zebrafish and mouse models, suggesting a promising therapeutic approach for Ewing sarcoma.

CANCER LETTERS (2023)

Article Biochemistry & Molecular Biology

Neurotrophic and Immunomodulatory Lanostane Triterpenoids from Wood-Inhabiting Basidiomycota

Khadija Hassan, Blondelle Matio Kemkuignou, Marco Kirchenwitz, Kathrin Wittstein, Monique Rascher-Albaghdadi, Clara Chepkirui, Josphat C. Matasyoh, Cony Decock, Reinhard W. Koster, Theresia E. B. Stradal, Marc Stadler

Summary: This study investigated the neurotrophic properties of compounds isolated from two types of mushrooms. The results showed that some of these compounds can stimulate the expression of neurotrophic factors and enhance neurite outgrowth. These findings suggest that these compounds have potential as therapeutic agents for neurodegenerative diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Oncology

YB-1 regulates mesothelioma cell migration via snail but not EGFR, MMP1, EPHA5 or PARK2

Karin Schelch, Sebastian Eder, Benjamin Zitta, Monica Phimmachanh, Thomas G. Johnson, Dominik Emminger, Andrea Wenninger-Weinzierl, Caterina Sturtzel, Hugo Poplimont, Alexander Ries, Konrad Hoetzenecker, Mir A. Hoda, Walter Berger, Martin Distel, Balazs Dome, Glen Reid, Michael Grusch

Summary: Pleural mesothelioma (PM) is a highly aggressive cancer with limited treatment options. The oncoprotein Y-box-binding protein-1 (YB-1) is overexpressed in cancer and has been shown to promote cancer cell migration. This study investigates the role of YB-1 in PM cell behavior and identifies snail as a critical regulator of YB-1-mediated cell motility. The findings provide insights into the mechanism underlying PM's aggressive nature and highlight the importance of YB-1 in this cancer.

MOLECULAR ONCOLOGY (2023)

Article Multidisciplinary Sciences

Comparative analysis of genome-scale, base-resolution DNA methylation profiles across 580 animal species

Johanna Klughammer, Daria Romanovskaia, Amelie Nemc, Annika Posautz, Charlotte A. Seid, Linda C. Schuster, Melissa C. Keinath, Juan Sebastian Lugo Ramos, Lindsay Kosack, Ann Evankow, Dieter Printz, Stefanie Kirchberger, Bekir Erguener, Paul Datlinger, Nikolaus Fortelny, Christian Schmidl, Matthias Farlik, Kaja Skjaerven, Andreas Bergthaler, Miriam Liedvogel, Denise Thaller, Pamela A. Burger, Marcela Hermann, Martin Distel, Daniel L. Distel, Anna Kuebber-Heiss, Christoph Bock

Summary: This study maps DNA methylation in 535 vertebrates and 45 invertebrates and establishes a reference dataset for cross-species analysis. It quantifies the association between DNA methylation and genomic DNA sequence throughout vertebrate evolution and reveals a deeply conserved association of DNA methylation with tissue type. The study also identifies evolutionary changes in DNA methylation at gene promoters for orthologous genes.

NATURE COMMUNICATIONS (2023)

Article Oncology

ROS Induction Targets Persister Cancer Cells with Low Metabolic Activity in NRAS-Mutated Melanoma

Ossia M. Eichhoff, Corinne I. Stoffel, Jan Kasler, Luzia Briker, Patrick Turko, Gergely Karsai, Nina Zila, Verena Paulitschke, Phil F. Cheng, Alexander Leitner, Andrea Bileck, Nicola Zamboni, Anja Irmisch, Zsolt Balazs, Aizhan Tastanova, Susana Pascoal, Pal Johansen, Rebekka Wegmann, Julien Mena, Alaa Othman, Vasanthi S. Viswanathan, Judith Wenzina, Andrea Aloia, Annalisa Saltari, Andreas Dzung, Michael Krauthammer, Stuart L. Schreiber, Thorsten Hornemann, Martin Distel, Berend Snijder, Reinhard Dummer, Mitchell P. Levesque

Summary: The clinical management of NRAS-mutated melanomas is challenging due to resistance that arises through genetic, transcriptional, and metabolic adaptation. However, the adoption of a mesenchymal phenotype with a quiescent metabolic program in NRAS-mutated melanoma cells confers sensitivity to reactive oxygen species (ROS) induction, which can be inhibited by ROS inducers in combination with MAPK pathway inhibitors. The findings suggest that targeting both metabolic reprogramming and MAPK signaling could improve patient treatment in melanoma and other cancers.

CANCER RESEARCH (2023)

Article Medicine, General & Internal

Systemic Inflammation and Normocytic Anemia in DOCK11 Deficiency

Jana Block, Christina Rashkova, Irinka Castanon, Samaneh Zoghi, Jessica Platon, Rico C. Ardy, Mitsuhiro Fujiwara, Beatriz Chaves, Rouven Schoppmeyer, Caspar I. van der Made, Raul Jimenez Heredia, Frederike L. Harms, Samin Alavi, Laia Alsina, Paula Sanchez Moreno, Rainiero Avila Polo, Rocio Cabrera-Perez, Sevgi Kostel Bal, Laurene Pfajfer, Bernhard Ransmayr, Anna-Katharina Mautner, Ryohei Kondo, Anna Tinnacher, Michael Caldera, Michael Schuster, Cecilia Dominguez Conde, Rene Platzer, Elisabeth Salzer, Thomas Boyer, Han G. Brunner, Judith E. Nooitgedagt-Frons, Estibaliz Iglesias, Angela Deya-Martinez, Marisol Camacho-Lovillo, Joerg Menche, Christoph Bock, Johannes B. Huppa, Winfried F. Pickl, Martin Distel, Jeffrey A. Yoder, David Traver, Karin R. Engelhardt, Tobias Linden, Leo Kager, J. Thomas Hannich, Alexander Hoischen, Sophie Hambleton, Sabine Illsinger, Lydie Da Costa, Kerstin Kutsche, Zahra Chavoshzadeh, Jaap D. van Buul, Jordi Anton, Joan Calzada-Hernandez, Olaf Neth, Julien Viaud, Akihiko Nishikimi, Loic Dupre, Kaan Boztug

Summary: This study reveals that DOCK11 regulates T-cell shape and migration as well as erythroid development. Inherited loss-of-function variants in DOCK11 resulted in early-onset severe immune dysregulation and normocytic anemia.

NEW ENGLAND JOURNAL OF MEDICINE (2023)

Review Oncology

Refined high-content imaging-based phenotypic drug screening in zebrafish xenografts

C. Sturtzel, S. Grissenberger, P. Bozatzi, E. Scheuringer, A. Wenninger-Weinzierl, Z. Zajec, J. Dernovsek, S. Pascoal, V. Gehl, A. Kutsch, A. Granig, F. Rifatbegovic, M. Carre, A. Lang, I. Valtingojer, J. Moll, D. Loetsch, F. Erhart, G. Widhalm, D. Surdez, O. Delattre, N. Andre, J. Stampfl, T. Tomasic, S. Taschner-Mandl, M. Distel

Summary: Zebrafish xenotransplantation models are increasingly used for phenotypic drug screening in precision oncology. This study presents a robust workflow for drug screening in zebrafish xenografts using high-content imaging. The authors established methods for embedding xenografts in 96-well format and provided strategies for automated imaging and analysis. The assay enables quantification of small compound efficacy in large cohorts of a vertebrate model system in vivo.

NPJ PRECISION ONCOLOGY (2023)

Article Biology

Nanoparticle-based targeting of microglia improves the neural regeneration enhancing effects of immunosuppression in the zebrafish retina

Kevin Emmerich, David T. T. White, Siva P. P. Kambhampati, Grace L. L. Casado, Tian-Ming Fu, Zeeshaan Chunawala, Arpan Sahoo, Saumya Nimmagadda, Nimisha Krishnan, Meera T. T. Saxena, Steven L. L. Walker, Eric Betzig, Rangaramanujam M. M. Kannan, Jeff S. S. Mumm

Summary: Analyzing microglial activity in a zebrafish model, the study shows the immunosuppressive effect of dexamethasone in vivo and the enhanced photoreceptor regeneration when conjugated to dendrimer nanoparticles. The study also discusses the potential mechanisms by which dexamethasone accelerates retinal regeneration and the effects of dendrimer-based targeting. Intravital time-lapse imaging revealed that post-injury dexamethasone inhibited microglia reactivity, and the dendrimer-conjugated formulation decreased toxicity and improved regeneration enhancing effects.

COMMUNICATIONS BIOLOGY (2023)

Article Cell Biology

An inducible model of chronic hyperglycemia

Tori R. Tucker, Courtney A. Knitter, Deena M. Khoury, Sheida Eshghi, Sophia Tran, Abigail Sharrock, Travis J. Wiles, David F. Ackerley, Jeff S. Mumm, Michael J. Parsons

Summary: Expression of Escherichia coli nitroreductase (NTR1.0) driven by a transgene makes animal cells susceptible to metronidazole (MTZ). Although NTR1.0/MTZ tools have been used in zebrafish studies, they are not suitable for chronic cell loss modeling due to the harmful effects of prolonged MTZ application. By using a more active nitroreductase (NTR2.0) that requires lower MTZ dose, the researchers established two new zebrafish lines for acute & beta;-cell ablation without MTZ-associated intestinal pathology. This study paves the way for modeling diabetes and related pathologies.

DISEASE MODELS & MECHANISMS (2023)

Article Biochemical Research Methods

Quantitative assessment of near-infrared fluorescent proteins

Hanbin Zhang, Stavrini Papadaki, Xiaoting Sun, Xinyue Wang, Mikhail Drobizhev, Luxia Yao, Michel Rehbock, Reinhard W. Koester, Lianfeng Wu, Kazuhiko Namikawa, Kiryl D. Piatkevich

Summary: Recent progress in the development of fluorescent proteins has led to the creation of a wide range of near-infrared fluorescent proteins (NIR FPs), which are increasingly being used in various imaging applications. However, the diversity of NIR FPs presents a challenge for end-users in selecting the most suitable one for a specific application. In this study, we conducted a systematic and quantitative assessment of 22 NIR FPs in cultured mammalian cells and primary mouse neurons, and identified a set of top-performing FPs that can cover a majority of imaging applications.

NATURE METHODS (2023)

暂无数据